Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jennifer M Margison"'
Publikováno v:
University of Manchester-PURE
Publikováno v:
British Journal of Clinical Pharmacology. 30:140-143
The effect of age on the pharmacokinetics of ifosfamide was studied in 20 patients with advanced non small cell lung cancer. A positive correlation was found between the elimination half-life of ifosfamide and age (r = 0.48, 0.05 less than P less tha
Autor:
Peter M Wilkinson, Jennifer M Margison, Michael J. Lind, S. B. Lucas, Miguel H. Bronchud, Anthony Howell
Publikováno v:
Cancer Chemotherapy and Pharmacology. 25:435-439
Recombinant human granulocyte colony-stimulating factor (G-CSF) has been shown to reduce neutropenia following cytotoxic therapy, thereby enabling dose escalation to improve the response rate. It is important to know whether drug kinetics change as d
Autor:
Anthony Howell, Mark Clemons, Audrey Griffiths, Hassan El Teraifi, Malcolm R Ranson, Geoffrey P. Margison, Charles Q Morris, Jane Kelly, Jennifer M Margison
Publikováno v:
International journal of cancer. 103(5)
We assessed whether split dosing with the methylating agent DTIC is an effective strategy for inactivating the DNA repair protein O6-alkylguanine DNA-ATase in order to decrease tumour resistance to BCNU. ATase levels in PBMCs were used as a surrogate
Publikováno v:
Critical reviews in oncology/hematology. 37(2)
Anthracyclines are amongst the most active drugs in the treatment of breast cancer. Stealth liposomal doxorubicin (Caelyx, Doxil, Alza Pharmaceuticals Inc.) is a promising new agent under investigation for the treatment of breast cancer and other sol
Autor:
Nick Thatcher, John Radford, Ric Swindell, Jennifer M Margison, Peter M Wilkinson, Michael J. Lind
Publikováno v:
Journal of cancer research and clinical oncology. 117
Dose fractionation is known to reduce the toxicity of ifosfamide and also results in an increased production of alkylating metabolites. Administration by slow infusion using the convenience of ambulatory pumps is therefore of interest. We used HPLC t
Publikováno v:
Cancer Chemotherapy and Pharmacology. 25:139-142
The pharmacokinetics of intravenous ifosfamide were determined in 16 patients with carcinoma of the bronchus. In all 25% (4) of these patients were obese (i.e. greater than 20% over their ideal body weight). The terminal elimination half-life (t1/2 b
Publikováno v:
Cancer Letters. 2:79-85
Rats were exposed chronically to unlabelled N,N-dimethylnitrosamine (25 ppm in the drinking water) then given a single dose of N-[3H]methyl-N-nitrosourea (10 mg/kg body weight). The rates of loss of tritium-labeled 7-methylguanine, O6-methylguanine a
Publikováno v:
Biomedical Chromatography. 1:101-103
A high performance liquid chromatography method is described for measuring Ifosfamide (I) in human serum. This involves solvent extraction, reverse phase HPLC and UV detection at 190 nm. Standard curves of peak height x detector sensitivity versus I
Publikováno v:
University of Manchester-PURE
The clinical pharmacology of 4-demethoxydaunorubicin (4-DMDNR) was studied in 28 patients with advanced breast cancer, using a sensitive reverse-phase HPLC technique. All patients had normal renal and hepatic function. The serum levels of 4-DMDNR aft